{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:36:53Z","timestamp":1793277413185,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000},"content-version":"vor","delay-in-days":115,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ50014"],"award-info":[{"award-number":["2023JJ50014"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Advanced Lung Cancer Targeted Therapy Research Foundation of China","award":["CTONG-YC20210303"],"award-info":[{"award-number":["CTONG-YC20210303"]}]},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University","award":["2022LNJJ10"],"award-info":[{"award-number":["2022LNJJ10"]}]},{"name":"ERC IMI","award":["101005122"],"award-info":[{"award-number":["101005122"]}]},{"name":"H2020","award":["952172"],"award-info":[{"award-number":["952172"]}]},{"name":"MRC","award":["MC\/PC\/21013"],"award-info":[{"award-number":["MC\/PC\/21013"]}]},{"name":"the Royal Society","award":["IEC\\NSFC\\211235"],"award-info":[{"award-number":["IEC\\NSFC\\211235"]}],"id":[{"id":"https:\/\/ror.org\/03wnrjx87","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the NVIDIA Academic Hardware Grant Program, the SABER project supported by Boehringer Ingelheim Ltd, NIHR Imperial Biomedical Research Centre","award":["RDA01"],"award-info":[{"award-number":["RDA01"]}],"id":[{"id":"https:\/\/ror.org\/01kmhx639","id-type":"ROR","asserted-by":"crossref"}]},{"name":"UKRI guarantee funding for Horizon Europe MSCA Postdoctoral Fellowships","award":["EP\/Z002206\/1"],"award-info":[{"award-number":["EP\/Z002206\/1"]}]},{"name":"UKRI MRC Research Grant, TFS Research Grants","award":["MR\/U506710\/1"],"award-info":[{"award-number":["MR\/U506710\/1"]}]},{"name":"Swiss National Science Foundation","award":["No. 220785"],"award-info":[{"award-number":["No. 220785"]}],"id":[{"id":"https:\/\/ror.org\/00yjd3n13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the UKRI Future Leaders Fellowship","award":["MR\/V023799\/1, UKRI2738"],"award-info":[{"award-number":["MR\/V023799\/1, UKRI2738"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accurate prediction of epidermal growth factor receptor (EGFR) mutation status in lung adenocarcinoma (LUAD) with brain metastases (BMs) is crucial for guiding targeted therapy. However, noninvasive and biologically interpretable tools remain limited. In this multicenter radiogenomic study, we analyzed a total of 1303 BMs from 421 LUAD patients across three institutions. 3435 radiomic features were extracted from T1, T2, and contrast-enhanced T1 sequences. A four-task classification framework was developed to predict EGFR mutation status (EGFR+, 19Del, L858R, or sensitizing mutation) using an adaptive LightGBM-based modeling pipeline. The models achieved excellent performance in the internal cohort (AUCs up to 0.95) and were further validated in 94 lesions with pathologically confirmed EGFR status, reaching an accuracy of 83.0%, sensitivity of 84.7%, and specificity of 80.0%. SHAP and LIME analyses revealed that shape-based radiomic features, particularly original_shape_sphericity, were the most important predictors of EGFR mutational subtypes. Then, we conducted transcriptomic analysis on 38 matched surgical specimens. Radiogenomic correlation revealed that sphericity negatively correlated with RNF125 and SLC37A2. Downstream enrichment analysis identified EGFR-associated features linked to DNA replication, sister chromatid segregation, and ERBB signaling. The study demonstrates that radiogenomic modeling, grounded in interpretable biology, holds promise as a non-invasive, clinical strategy for precision stratification of LUAD BMs.<\/jats:p>","DOI":"10.1038\/s41746-026-02931-9","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T20:05:30Z","timestamp":1783368330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiogenomic modeling of EGFR mutation status in brain metastases from lung adenocarcinoma: a multicenter study with biological interpretability"],"prefix":"10.1038","volume":"9","author":[{"given":"Fuxing","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilong","family":"Tanzhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-8025","authenticated-orcid":false,"given":"Zijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-0615","authenticated-orcid":false,"given":"Rongrong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"2931_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"2931_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107634","volume":"26","author":"X Chu","year":"2023","unstructured":"Chu, X. et al. Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: a multicenter trial. iScience 26, 107634 (2023).","journal-title":"iScience"},{"key":"2931_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.875488","volume":"13","author":"X Chu","year":"2022","unstructured":"Chu, X. et al. The long-term and short-term efficacy of immunotherapy in non-small cell lung cancer patients with brain metastases: a systematic review and meta-analysis. Front. Immunol. 13, 875488 (2022).","journal-title":"Front. Immunol."},{"key":"2931_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04089-4","volume":"21","author":"W Tian","year":"2023","unstructured":"Tian, W., Chu, X., Tanzhu, G. & Zhou, R. Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis. J. Transl. Med. 21, 244 (2023).","journal-title":"J. Transl. Med."},{"key":"2931_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.jtho.2016.06.002","volume":"11","author":"J Khalifa","year":"2016","unstructured":"Khalifa, J. et al. Brain metastases from NSCLC: radiation therapy in the era of targeted therapies. J. Thorac. Oncol. 11, 1627\u20131643 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"2931_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lungcan.2022.11.009","volume":"175","author":"J Subramanian","year":"2023","unstructured":"Subramanian, J. et al. Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: an international observational study. Lung Cancer 175, 47\u201356 (2023).","journal-title":"Lung Cancer"},{"key":"2931_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","volume":"1867","author":"FJ Lowery","year":"2017","unstructured":"Lowery, F. J. & Yu, D. Brain metastasis: unique challenges and open opportunities. Biochim Biophys. Acta Rev. Cancer 1867, 49\u201357 (2017).","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"2931_CR8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos, P. K. et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 5, 1164\u20131177 (2015).","journal-title":"Cancer Discov."},{"key":"2931_CR9","doi-asserted-by":"crossref","unstructured":"Jelski, W. & Mroczko, B. Molecular and circulating biomarkers of brain tumors. Int. J. Mol. Sci. 22, 7039 (2021).","DOI":"10.3390\/ijms22137039"},{"key":"2931_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin, P. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749\u2013762 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2931_CR11","volume":"2021","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Handcrafted and deep learning-based radiomic models can distinguish GBM from brain metastasis. J. Oncol. 2021, 5518717 (2021).","journal-title":"J. Oncol."},{"key":"2931_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s13246-023-01300-0","volume":"46","author":"F Deng","year":"2023","unstructured":"Deng, F. et al. MRI radiomics for brain metastasis sub-pathology classification from non-small cell lung cancer: a machine learning, multicenter study. Phys. Eng. Sci. Med. 46, 1309\u20131320 (2023).","journal-title":"Phys. Eng. Sci. Med"},{"key":"2931_CR13","doi-asserted-by":"crossref","unstructured":"Le, N. Q. K. et al. Machine learning-based radiomics signatures for EGFR and KRAS mutations prediction in non-small-cell lung cancer. Int. J. Mol. Sci. 22, 9254 (2021).","DOI":"10.3390\/ijms22179254"},{"key":"2931_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.molmed.2022.11.002","volume":"29","author":"K Hartmann","year":"2023","unstructured":"Hartmann, K., Sadee, C. Y., Satwah, I., Carrillo-Perez, F. & Gevaert, O. Imaging genomics: data fusion in uncovering disease heritability. Trends Mol. Med. 29, 141\u2013151 (2023).","journal-title":"Trends Mol. Med."},{"key":"2931_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41416-023-02317-8","volume":"129","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Radiogenomics: a key component of precision cancer medicine. Br. J. Cancer 129, 741\u2013753 (2023).","journal-title":"Br. J. Cancer"},{"key":"2931_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65470-7","volume":"10","author":"SJ Ahn","year":"2020","unstructured":"Ahn, S. J. et al. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer. Sci. Rep. 10, 8905 (2020).","journal-title":"Sci. Rep."},{"key":"2931_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/neuonc\/noaa030","volume":"22","author":"TJ Kaufmann","year":"2020","unstructured":"Kaufmann, T. J. et al. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol. 22, 757\u2013772 (2020).","journal-title":"Neuro Oncol."},{"key":"2931_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/RTI.0000000000000116","volume":"29","author":"JS Hsu","year":"2014","unstructured":"Hsu, J. S. et al. Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma. J. Thorac. Imaging 29, 357\u2013363 (2014).","journal-title":"J. Thorac. Imaging"},{"key":"2931_CR19","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.celrep.2015.04.049","volume":"11","author":"H Kim","year":"2015","unstructured":"Kim, H. et al. Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation. Cell Rep. 11, 1458\u20131473 (2015).","journal-title":"Cell Rep."},{"key":"2931_CR20","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/s41388-023-02710-w","volume":"42","author":"Z Feng","year":"2023","unstructured":"Feng, Z. et al. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. Oncogene 42, 2017\u20132030 (2023).","journal-title":"Oncogene"},{"key":"2931_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1297363","volume":"14","author":"X Sui","year":"2023","unstructured":"Sui, X. & Wu, G. Immune landscape and prognostic gene signatures in gastric cancer: implications for cachexia and clinical outcomes. Front. Immunol. 14, 1297363 (2023).","journal-title":"Front. Immunol."},{"key":"2931_CR22","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/cam4.5002","volume":"12","author":"W Xiao","year":"2023","unstructured":"Xiao, W. et al. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma. Cancer Med. 12, 2117\u20132133 (2023).","journal-title":"Cancer Med."},{"key":"2931_CR23","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/ATVBAHA.108.168641","volume":"28","author":"P Russo","year":"2008","unstructured":"Russo, P. et al. Genetic variants of Y chromosome are associated with a protective lipid profile in black men. Arterioscler. Thromb. Vasc. Biol. 28, 1569\u20131574 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2931_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2353\/jmoldx.2007.060198","volume":"9","author":"KM Murphy","year":"2007","unstructured":"Murphy, K. M., Cohen, J. S., Goodrich, A., Long, P. P. & Griffin, C. A. Constitutional duplication of a region of chromosome Yp encoding AMELY, PRKY, and TBL1Y: implications for sex chromosome analysis and bone marrow engraftment analysis. J. Mol. Diagn. 9, 408\u2013413 (2007).","journal-title":"J. Mol. Diagn."},{"key":"2931_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrc1669","volume":"5","author":"AJ Simpson","year":"2005","unstructured":"Simpson, A. J., Caballero, O. L., Jungbluth, A., Chen, Y. T. & Old, L. J. Cancer\/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615\u2013625 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"2931_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0952-7915(97)80050-7","volume":"9","author":"BJ Van den Eynde","year":"1997","unstructured":"Van den Eynde, B. J. & van der Bruggen, P. T cell defined tumor antigens. Curr. Opin. Immunol. 9, 684\u2013693 (1997).","journal-title":"Curr. Opin. Immunol."},{"key":"2931_CR27","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1200\/JCO.2012.43.7103","volume":"31","author":"J Vansteenkiste","year":"2013","unstructured":"Vansteenkiste, J. et al. Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results. J. Clin. Oncol. 31, 2396\u20132403 (2013).","journal-title":"J. Clin. Oncol."},{"key":"2931_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","volume":"17","author":"JF Vansteenkiste","year":"2016","unstructured":"Vansteenkiste, J. F. et al. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 17, 822\u2013835 (2016).","journal-title":"Lancet Oncol."},{"key":"2931_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05755-7","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. PLCG2 can exist in eccDNA and contribute to the metastasis of non-small cell lung cancer by regulating mitochondrial respiration. Cell Death Dis. 14, 257 (2023).","journal-title":"Cell Death Dis."},{"key":"2931_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23588","volume":"35","author":"H Yu","year":"2021","unstructured":"Yu, H., Pang, Z., Li, G. & Gu, T. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. J. Clin. Lab Anal. 35, e23588 (2021).","journal-title":"J. Clin. Lab Anal."},{"key":"2931_CR31","doi-asserted-by":"crossref","unstructured":"Yang, L. et al. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. J. Immunother. Cancer 10, e003534 (2022).","DOI":"10.1136\/jitc-2021-003534"},{"key":"2931_CR32","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1158\/2159-8290.CD-20-0725","volume":"11","author":"S Venkatesan","year":"2021","unstructured":"Venkatesan, S. et al. Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution. Cancer Discov. 11, 2456\u20132473 (2021).","journal-title":"Cancer Discov."},{"key":"2931_CR33","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/jmri.28751","volume":"58","author":"Y Fan","year":"2023","unstructured":"Fan, Y. et al. Brain-tumor interface-based mri radiomics models to determine EGFR mutation, response to EGFR-TKI and T790M resistance mutation in non-small cell lung carcinoma brain metastasis. J. Magn. Reson. Imaging 58, 1838\u20131847 (2023).","journal-title":"J. Magn. Reson. Imaging"},{"key":"2931_CR34","doi-asserted-by":"publisher","unstructured":"Cao, R. et al. Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study. Phys. Med. Biol. 67, https:\/\/doi.org\/10.1088\/1361-6560\/ac7192 (2022).","DOI":"10.1088\/1361-6560\/ac7192"},{"key":"2931_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2025.103855","volume":"107","author":"T Zhou","year":"2026","unstructured":"Zhou, T., Ruan, S. & Lei, B. BUFNet: boundary-aware and uncertainty-driven multi-modal fusion network for MR brain tumor segmentation. Med. Image Anal. 107, 103855 (2026).","journal-title":"Med. Image Anal."},{"key":"2931_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mri.2024.01.014","volume":"108","author":"X Xiang","year":"2024","unstructured":"Xiang, X., Li, X., Lin, H. & Wang, X. Amide proton transfer-weighted MRI in predicting pathological types of brain metastases in lung Cancer. Magn. Reson. Imaging 108, 59\u201366 (2024).","journal-title":"Magn. Reson. Imaging"},{"key":"2931_CR37","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/j.crad.2023.10.022","volume":"79","author":"Z Huang","year":"2024","unstructured":"Huang, Z. et al. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma. Clin. Radio. 79, e305\u2013e316 (2024).","journal-title":"Clin. Radio."},{"key":"2931_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s10278-017-0037-8","volume":"31","author":"Z Yaniv","year":"2018","unstructured":"Yaniv, Z., Lowekamp, B. C., Johnson, H. J. & Beare, R. SimpleITK image-analysis notebooks: a collaborative environment for education and reproducible research. J. Digit. Imaging 31, 290\u2013303 (2018).","journal-title":"J. Digit. Imaging"},{"key":"2931_CR39","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen, J. J. M. et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77, e104\u2013e107 (2017).","journal-title":"Cancer Res."},{"key":"2931_CR40","doi-asserted-by":"crossref","unstructured":"Xiao, G. et al. Heterogeneity of tumor immune microenvironment of EGFR\/ALK-positive tumors versus EGFR\/ALK-negative tumors in resected brain metastases from lung adenocarcinoma. J. Immunother. Cancer 11, e006243 (2023).","DOI":"10.1136\/jitc-2022-006243"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02931-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02931-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02931-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:15:07Z","timestamp":1793276107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02931-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2931"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02931-9","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.Y. is a member of the Editorial Board of npj Digital Medicine but was not involved in the peer review process or decision-making for this manuscript. The manuscript was handled independently by other members of the editorial team. All authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"822"}}